For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Enzo Biochem, Inc.

USPTO Granted Patents = 81

% Expired Patents = 8.6

CIPO Patents = 4

EPO Patents = 21

Trademarks = 17

Forward Citations = 2,087

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Elazar S Rabbani (37 out of 122 patents)

James J Donegan (31 out of 84 patents)

Jannis G Stavrianopoulos (28 out of 95 patents)

4. Jack Coleman (16 out of 63 patents)

5. Praveen Pande (11 out of 44 patents)

6. Xiaofeng Li (8 out of 17 patents)

7. Dakai Liu (8 out of 28 patents)

8. Joshua Rabbani (7 out of 14 patents)

9. Zaiguo Li (7 out of 18 patents)

10. Dean L Engelhardt (7 out of 18 patents)

11. Natarajan Raju (6 out of 27 patents)

12. Wayne Forrest Patton (6 out of 41 patents)

13. Gerard Nuovo (4 out of 5 patents)

14. Virginia Nivar (4 out of 4 patents)

15. Richard Jin (3 out of 10 patents)

Core Competencies:

Nucleic Acid Detection

Immunomodulatory Compositions

Viral Diseases

Sphingosine Pathway

Wnt Pathway

Pharmaceutical Compositions

DNA Labeling

Hybridization Assays

Bone Formation

Fluorescent Dyes

Quantitative Detection

Analytical Processes

81 patents: Sort by Forward Citations

1. 12442031 - DNA labeling compositions and methods for comparative genomic hybridization (2025-10-14),

2. 12122921 - Fluorescence quencher polymer conjugates and uses thereof (2024-10-22),

3. 12061198 - Diagnosis and treatment of viral diseases (2024-08-13),

4. 11938167 - Pharmaceutical compositions and methods targeting Wnt pathway proteins (2024-03-26),

5. 11931344 - Sphingosine pathway modulating compounds for the treatment of coronavirus infection (2024-03-19),

6. 11865105 - Sphingosine pathway modulating compounds for the treatment of cancers (2024-01-09),

7. 11723895 - Sphingosine pathway modulating compounds for the treatment of coronavirus infection (2023-08-15),

8. 11667703 - Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor (2023-06-06),

9. 11639382 - Antibodies specific for sulfation sites of Wnt pathway proteins (2023-05-02),

10. 11554111 - Sphingosine pathway modulating compounds for the treatment of coronavirus infection (2023-01-17),

11. 11173195 - Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta (2021-11-16),

12. 11167011 - Methods for treating bone loss using sclerostin peptides (2021-11-09),

13. 11066694 - Affinity tag nucleic acid and protein compositions, and processes for using same (2021-07-20),

14. 10899827 - Antibodies specific for sulfation sites of sclerostin (2021-01-26),

15. 10881643 - Sphingosine pathway modulating compounds for the treatment of cancers (2021-01-05),

Company Overview

Enzo Biochem, Inc. is a biotechnology company based in New York, specializing in nucleic acid detection and related technologies. The organization focuses on developing innovative solutions for the diagnosis and treatment of viral diseases, utilizing advanced methodologies in immunomodulatory compositions and pharmaceutical formulations. Enzo's expertise extends to the sphingosine and Wnt pathways, as well as DNA labeling and hybridization assays, positioning it as a key player in the life sciences sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

81 Patents

#123 in New York, NY

#274 in New York

#4,579 in US

#9,354 in the World

New York, NY, United States of America

Enzo Biochem, Inc.

Forward Citations = 2,087

65 inventors:

Elazar S Rabbani (37 out of 122 patents)

James J Donegan (31 out of 84 patents)

Jannis G Stavrianopoulos (28 out of 95 patents)

4. Jack Coleman (16 out of 63 patents)

5. Praveen Pande (11 out of 44 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enzo Biochem, Inc.. Retrieved from https://idiyas.com/company/enzo-biochem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…